Thyroid-split tracheostomy: short- and long-term outcomes.

IF 2.1 4区 医学 Q2 OTORHINOLARYNGOLOGY Acta Otorhinolaryngologica Italica Pub Date : 2023-04-01 DOI:10.14639/0392-100X-N2192
Nir Tsur, Ella Segal, Eyal Yosefof, Noam Koch, Idan Zeeman, Ella Reifen, Ory Wiesel, Gideon Bachar, Esmat Najjar
{"title":"Thyroid-split tracheostomy: short- and long-term outcomes.","authors":"Nir Tsur,&nbsp;Ella Segal,&nbsp;Eyal Yosefof,&nbsp;Noam Koch,&nbsp;Idan Zeeman,&nbsp;Ella Reifen,&nbsp;Ory Wiesel,&nbsp;Gideon Bachar,&nbsp;Esmat Najjar","doi":"10.14639/0392-100X-N2192","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Compare long-term outcomes of thyroid-split and standard thyroid-retraction tracheostomy in a large cohort.</p><p><strong>Methods: </strong>The healthcare database of a university-affiliated hospital was searched for past patients over 18 years of age from all of the hospital's wards on whom an ear, nose, and throat specialist performed a tracheostomy in the operating room between 2010 and 2020. Clinical data were extracted from the hospital and outpatient medical records. Life-threatening and non-life-threatening intra-operative and early and late post-operative adverse events in patients who underwent split-thyroid tracheostomy were compared with those who underwent standard tracheostomy.</p><p><strong>Results: </strong>There was no significant difference in intra-operative and early post-operative complications, hospitalisation length, or early reoperation and death rates between the 140 (28%) thyroid-split tracheostomy patients and the 354 (72%) standard tracheostomy patients, although the thyroid-split group had more non-decannulated patients and a longer operative time.</p><p><strong>Conclusions: </strong>Thyroid-split tracheostomy is safe and feasible. Compared to the standard procedure, it provides better exposure and a similar rate of complications, although its de-cannulation success rate is lower.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"43 2","pages":"99-107"},"PeriodicalIF":2.1000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6e/5d/aoi-2023-02-99.PMC10132481.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Otorhinolaryngologica Italica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14639/0392-100X-N2192","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Compare long-term outcomes of thyroid-split and standard thyroid-retraction tracheostomy in a large cohort.

Methods: The healthcare database of a university-affiliated hospital was searched for past patients over 18 years of age from all of the hospital's wards on whom an ear, nose, and throat specialist performed a tracheostomy in the operating room between 2010 and 2020. Clinical data were extracted from the hospital and outpatient medical records. Life-threatening and non-life-threatening intra-operative and early and late post-operative adverse events in patients who underwent split-thyroid tracheostomy were compared with those who underwent standard tracheostomy.

Results: There was no significant difference in intra-operative and early post-operative complications, hospitalisation length, or early reoperation and death rates between the 140 (28%) thyroid-split tracheostomy patients and the 354 (72%) standard tracheostomy patients, although the thyroid-split group had more non-decannulated patients and a longer operative time.

Conclusions: Thyroid-split tracheostomy is safe and feasible. Compared to the standard procedure, it provides better exposure and a similar rate of complications, although its de-cannulation success rate is lower.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
甲状腺分裂气管切开术:短期和长期的结果。
目的:比较大队列中甲状腺分裂气管切开术和标准甲状腺后缩气管切开术的远期疗效。方法:检索某大学附属医院的卫生保健数据库,检索2010年至2020年期间在该医院所有病房进行过耳鼻喉科专家气管切开术的18岁以上患者。临床资料提取自医院和门诊病历。比较甲状腺裂气管切开术患者术中危及生命和非危及生命的不良事件以及术后早期和晚期的不良事件。结果:140例甲裂气管造口术患者(28%)与354例标准气管造口术患者(72%)在术中、术后早期并发症、住院时间、早期再手术及死亡率方面无显著差异,但甲裂气管造口术组非脱管患者较多,手术时间较长。结论:甲状裂气管切开术安全可行。与标准程序相比,它提供了更好的暴露和相似的并发症发生率,尽管其脱管成功率较低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta Otorhinolaryngologica Italica
Acta Otorhinolaryngologica Italica OTORHINOLARYNGOLOGY-
CiteScore
3.40
自引率
10.00%
发文量
97
审稿时长
6-12 weeks
期刊介绍: Acta Otorhinolaryngologica Italica first appeared as “Annali di Laringologia Otologia e Faringologia” and was founded in 1901 by Giulio Masini. It is the official publication of the Italian Hospital Otology Association (A.O.O.I.) and, since 1976, also of the Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale (S.I.O.Ch.C.-F.). The journal publishes original articles (clinical trials, cohort studies, case-control studies, cross-sectional surveys, and diagnostic test assessments) of interest in the field of otorhinolaryngology as well as clinical techniques and technology (a short report of unique or original methods for surgical techniques, medical management or new devices or technology), editorials (including editorial guests – special contribution) and letters to the Editor-in-Chief. Articles concerning science investigations and well prepared systematic reviews (including meta-analyses) on themes related to basic science, clinical otorhinolaryngology and head and neck surgery have high priority.
期刊最新文献
The prognostic role of salivary miRNAs in oral squamous cell carcinoma: technical challenges and clinical perspectives. Laryngopharyngeal reflux: knowledge, attitudes, and practices among primary healthcare physicians. Long-term safety and subjective satisfaction of Bonebridge and Vibrant Soundbridge in congenital unilateral conductive hearing loss. Modular anatomic approach to oral tongue carcinoma: functional outcomes and quality of life. Role of PET/CT in improving the cost effectiveness of nimotuzumab in nasopharyngeal carcinoma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1